跳至主要内容
临床试验/NCT02389855
NCT02389855已完成不适用

Laser Ablation in Stereotactic Neurosurgery

Monteris Medical9 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
144
试验地点
9
主要终点
Endpoint 1: Procedural Success Endpoint 2: Progression-Free Survival Endpoint 3: Overall Survival Endpoint 4: Karnofsky performance status

研究概览

简要总结

The NeuroBlate® System (NBS), is a minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. Since receiving FDA clearance in April 2013, the NBS has been used in nearly 300 procedures conducted at approximately 20 leading institutions across the United States. This post-market, multi-center retrospective study is designed to collect long-term follow-up data on patients who were treated previously with NBS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient was previously treated with NBS
  • Patient is willing and able to provide informed consent and authorization for release of personal health information or IRB waiver is granted to collect study information without patient consent

排除标准

  • There are no exclusion criteria for this study.

结局指标

主要结局

Endpoint 1: Procedural Success Endpoint 2: Progression-Free Survival Endpoint 3: Overall Survival Endpoint 4: Karnofsky performance status

时间窗: up to 24 months

Retrospective data collection.

次要结局

  • Adverse Events(up to 24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验

Laser Ablation in Stereotactic Neurosurgery (LAISE):... | 临床试验